BALCHEM CORPORATION — Key Metrics
2 years of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Expense Ratios
R&D / Revenue
1.8%
SBC / Revenue
1.7%
Capex / Revenue
—
2 years of history · ending 2025-12-31 · SEC EDGAR
Phase 1: currency selection stored in the URL. Conversion ships in Phase 2 (see ADR-0003).